TOKYO -- Fujifilm Holdings announced on Thursday that it will start U.S. clinical trials of Avigan, its flu-fighter that is said to be effective in treating the novel coronavirus, within the week. The trials, which will evaluate the safety and efficacy of the drug, will enlist about 50 COVID-19 patients.
Pharmaceuticals
Fujifilm to begin Avigan trials in US with coronavirus patients
Phase 2 testing on new use of flu drug to enlist 50 subjects and go through June
Japan has said it will make Avigan available at no cost to countries that ask for it as a coronavirus remedy. (Photo by Takaki Kashiwabara)
Read Next
Latest on Pharmaceuticals
